Additionally, the high SOX9 expression could significantly predict the poorer histological differentiation in GC patients (OR = 0.62; 95% CI: 0.36–1.06; P = .002; Fig. 3D), and the random-effects model was performed due to the significant heterogeneity. The gene discussed is SOX9; the disease is gastric cancer.